Bob G. Gower, Director at Ensysce Biosciences, Inc. (ENSC), bought 714,286 shares at $1.40 ($1.0M) on 2022-12-09, disclosed to the SEC on 2023-02-01.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Clearly above the average filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.40 | 357,143 | $500K | 50.0% |
| 2 | $1.40 | 357,143 | $500K | 50.0% |
| Total | $1.40 avg | 714,286 | $1.0M | 100% |
| Filing → |
| ENSC | BUY | 2023-03-02 | $183K | — | Filing → |
| MILL | BUY | 2015-01-06 | $43K | — | Filing → |
| MILL | BUY | 2014-12-22 | $76K | — | Filing → |